⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TNYA News
Tenaya Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
QNCX
GSK
AZN
ZYME
TNYA
NTAP
EXEL
NVS
KLRS
NKTX
CLYM
INSM
Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
globenewswire.com
TNYA
Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
globenewswire.com
TNYA
Form 8-K
sec.gov
TNYA
Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
TNYA
Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
globenewswire.com
TNYA
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
TNYA
Form 8-K
sec.gov
TNYA
Form 8-K
sec.gov
TNYA
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
globenewswire.com
TNYA